NCT00989729

Preoperative Methylprednisolone in Endovascular Aortic Repair

Preoperative Methylprednisolone in Endovascular Aortic Repair - a Randomized Double Blind Placebo Controlled Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Louise de la Motte · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednisolone.

Conditions

• Abdominal Aortic Aneurysms

Interventions

Type	Name	Description
DRUG	Methylprednisolone	A single preoperative dosage 30 mg/kg Methylprednisolone suspended in physiological saline (100 ml in total) given intravenously as a 30 minute infusion, 2 hours before surgery.
DRUG	Physiological Saline	A single preoperative dosage 100 ml given intravenously as a 30 minute infusion, 2 hours before surgery

Timeline

• Start date: 2009-10-01
• Primary completion: 2013-01-01
• Completion: 2013-04-01
• First posted: 2009-10-05
• Last updated: 2014-11-14

Locations

1 site across 1 country: Denmark